Palvella Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Palvella Therapeutics, Inc. (PVLA) reported Basic Shares Outstanding (Weighted Average) of 14.36 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-04
- Palvella Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 14.36M shares, a 29.89% increase year-over-year.
- Palvella Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 13.09M shares, a 18.81% increase year-over-year.
- Palvella Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 11.87M shares, a 230.45% increase year-over-year.
- Palvella Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 11.06M shares, a 525.04% increase year-over-year.
- Palvella Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 11.25M shares, a 405.46% increase from fiscal 2024.
- Palvella Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 2.23M shares, a 25.75% increase from fiscal 2023.
- Palvella Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 1.77M shares, a 97.61% decline from fiscal 2022.
- Palvella Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 74.17M shares, a 14.91% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 1 month | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 7 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed | Weighted Average Number of Shares Outstanding, Basic 13 month | Weighted Average Number of Shares Outstanding, Basic 16 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 14.36M shares 10-Q · filed 2026-08-04 | 13.72M shares 10-Q · filed 2026-08-04 | 13.11M shares derived: average of 3 quarters · filed 2026-08-04 | 12.59M shares derived: average of 4 quarters · filed 2026-08-04 | ||||||||
| 2026-03-31 | 13.09M shares 10-Q · filed 2026-05-07 | 12.48M shares derived: average of 2 quarters · filed 2026-05-07 | 12.01M shares derived: average of 3 quarters · filed 2026-05-07 | 11.77M shares derived: average of 4 quarters · filed 2026-08-04 | ||||||||
| 2025-12-31 | 11.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 11.47M shares derived: average of 2 quarters · filed 2026-03-31 | 11.33M shares derived: average of 3 quarters · filed 2026-08-04 | 11.25M shares 10-K · filed 2026-03-31 | ||||||||
| 2025-09-30 | 11.06M shares 10-Q · filed 2025-11-12 | 11.06M shares derived: average of 2 quarters · filed 2026-08-04 | 11.04M shares 10-Q · filed 2025-11-12 | 9.18M shares derived: average of 4 quarters · filed 2026-08-04 | ||||||||
| 2025-06-30 | 11.05M shares 10-Q · filed 2026-08-04 | 11.03M shares 10-Q · filed 2026-08-04 | 8.55M shares derived: average of 3 quarters · filed 2026-08-04 | 6.86M shares derived: average of 4 quarters · filed 2026-08-04 | ||||||||
| 2025-03-31 | 11.01M shares 10-Q · filed 2026-05-07 | 7.30M shares derived: average of 2 quarters · filed 2026-05-07 | 5.46M shares derived: average of 3 quarters · filed 2026-05-07 | 4.54M shares derived: average of 4 quarters · filed 2026-05-07 | ||||||||
| 2024-12-31 | 3.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 2.68M shares derived: average of 2 quarters · filed 2026-03-31 | 2.38M shares derived: average of 3 quarters · filed 2026-03-31 | 2.23M shares 10-K · filed 2026-03-31 | ||||||||
| 2024-09-30 | 1.77M shares 10-Q · filed 2025-11-12 | 1.32M shares 10-Q · filed 2024-11-13 | 1.77M shares derived: average of 2 quarters · filed 2025-11-12 | 1.77M shares 10-Q · filed 2025-11-12 | 1.28M shares 10-Q · filed 2024-11-13 | 2.28M shares derived: average of 4 quarters · filed 2025-11-12 | ||||||
| 2024-06-30 | 1.77M shares 10-Q · filed 2025-08-14 | 1.30M shares 10-Q · filed 2024-08-14 | 1.77M shares 10-Q · filed 2025-08-14 | 1.27M shares 10-Q · filed 2024-08-14 | 2.45M shares derived: average of 3 quarters · filed 2025-08-14 | 2.15M shares derived: average of 4 quarters · filed 2025-08-14 | ||||||
| 2024-03-31 | 1.77M shares 10-Q · filed 2025-05-15 | 1.24M shares 10-Q · filed 2024-05-15 | 2.79M shares derived: average of 2 quarters · filed 2025-05-15 | 2.27M shares derived: average of 3 quarters · filed 2025-05-15 | 1.98M shares derived: average of 4 quarters · filed 2025-05-15 | |||||||
| 2023-12-31 | 3.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 2.52M shares derived: average of 2 quarters · filed 2025-03-31 | 2.05M shares derived: average of 3 quarters · filed 2025-03-31 | 1.77M shares 10-K · filed 2025-03-31 | 90.06M shares 10-K · filed 2024-03-29 | |||||||
| 2023-09-30 | 1.24M shares 10-Q · filed 2024-11-13 | 98.85M shares 10-Q · filed 2023-11-14 | 1.17M shares derived: average of 2 quarters · filed 2024-11-13 | 1.09M shares 10-Q · filed 2024-11-13 | 87.09M shares 10-Q · filed 2023-11-14 | 19.43M shares derived: average of 4 quarters · filed 2024-11-13 | ||||||
| 2023-06-30 | 1.09M shares 10-Q · filed 2024-08-14 | 87.64M shares 10-Q · filed 2023-08-10 | 1.01M shares 10-Q · filed 2024-08-14 | 81.11M shares 10-Q · filed 2023-08-10 | 25.49M shares derived: average of 3 quarters · filed 2024-08-14 | 37.72M shares derived: average of 4 quarters · filed 2024-08-14 | ||||||
| 2023-03-31 | 931.00K shares 10-Q · filed 2024-05-15 | 74.52M shares 10-Q · filed 2023-05-11 | 37.69M shares derived: average of 2 quarters · filed 2024-05-15 | 49.93M shares derived: average of 3 quarters · filed 2024-05-15 | 55.98M shares derived: average of 4 quarters · filed 2024-05-15 | |||||||
| 2022-12-31 | 74.45M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 74.42M shares derived: average of 2 quarters · filed 2024-03-29 | 74.32M shares derived: average of 3 quarters · filed 2024-03-29 | 74.17M shares 10-K · filed 2024-03-29 | ||||||||
| 2022-09-30 | 74.40M shares 10-Q · filed 2023-11-14 | 74.26M shares derived: average of 2 quarters · filed 2023-11-14 | 74.08M shares 10-Q · filed 2023-11-14 | 73.59M shares derived: average of 4 quarters · filed 2023-11-14 | ||||||||
| 2022-06-30 | 74.13M shares 10-Q · filed 2023-08-10 | 73.92M shares 10-Q · filed 2023-08-10 | 73.32M shares derived: average of 3 quarters · filed 2023-08-10 | 71.92M shares derived: average of 4 quarters · filed 2023-08-10 | ||||||||
| 2022-03-31 | 73.71M shares 10-Q · filed 2023-05-11 | 72.92M shares derived: average of 2 quarters · filed 2023-05-11 | 71.19M shares derived: average of 3 quarters · filed 2023-05-11 | 68.87M shares derived: average of 4 quarters · filed 2023-05-11 | ||||||||
| 2021-12-31 | 72.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 69.93M shares derived: average of 2 quarters · filed 2023-03-31 | 67.26M shares derived: average of 3 quarters · filed 2023-03-31 | 64.55M shares 10-K · filed 2023-03-31 | ||||||||
| 2021-09-30 | 67.73M shares 10-Q · filed 2022-11-04 | 64.82M shares derived: average of 2 quarters · filed 2022-11-04 | 62.02M shares 10-Q · filed 2022-11-04 | 60.48M shares derived: average of 4 quarters · filed 2022-11-04 | ||||||||
| 2021-06-30 | 61.91M shares 10-Q · filed 2022-08-04 | 59.12M shares 10-Q · filed 2022-08-04 | 58.07M shares derived: average of 3 quarters · filed 2022-08-04 | 57.13M shares derived: average of 4 quarters · filed 2022-08-04 | ||||||||
| 2021-03-31 | 56.30M shares 10-Q · filed 2022-05-11 | 56.15M shares derived: average of 2 quarters · filed 2022-05-11 | 55.54M shares derived: average of 3 quarters · filed 2022-05-11 | 54.75M shares derived: average of 4 quarters · filed 2022-05-11 | ||||||||
| 2020-12-31 | 56.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | 55.17M shares derived: average of 2 quarters · filed 2022-03-02 | 54.24M shares derived: average of 3 quarters · filed 2022-03-02 | 54.48M shares 10-K · filed 2022-03-02 | ||||||||
| 2020-09-30 | 54.34M shares 10-Q · filed 2021-11-02 | 53.36M shares derived: average of 2 quarters · filed 2021-11-02 | 53.98M shares 10-Q · filed 2021-11-02 | |||||||||
| 2020-06-30 | 52.37M shares 10-Q · filed 2021-08-05 | 53.79M shares 10-Q · filed 2021-08-05 | ||||||||||
| 2014-09-30 | 6.25M shares 10-Q · filed 2014-11-13 | 7.83M shares derived: average of 2 quarters · filed 2014-11-13 | 6.88M shares derived: average of 3 quarters · filed 2014-11-13 | 6.41M shares derived: average of 4 quarters · filed 2014-11-13 | 5.00M shares 10-Q · filed 2014-11-13 | |||||||
| 2014-06-30 | 9.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-12 | 7.20M shares derived: average of 2 quarters · filed 2014-09-12 | 6.47M shares derived: average of 3 quarters · filed 2014-09-12 | 6.10M shares 10-K · filed 2014-09-12 | 5.00M shares 10-K · filed 2014-09-12 | |||||||
| 2014-03-31 | 5.00M shares 10-Q · filed 2014-06-02 | 5.00M shares derived: average of 2 quarters · filed 2014-06-02 | 5.00M shares 10-Q · filed 2014-06-02 | |||||||||
| 2013-12-31 | 5.00M shares 10-Q · filed 2014-05-14 | 5.00M shares 10-Q · filed 2014-05-14 | 5.00M shares 10-Q · filed 2014-05-14 | |||||||||
| 2013-09-30 | 6.10M shares 10-Q · filed 2014-11-13 | |||||||||||
| 2013-06-30 | 5.00M shares 10-K · filed 2014-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |